Efficacy and Safety of Semaglutide Versus Canagliflozin as add-on to Metformin in Subjects With Type 2 Diabetes
Clinical trial NCT03136484 · COMPLETED
Trial details
- NCT number
- NCT03136484
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-15
- Primary completion
- 2018-10-16
- Enrollment
- 788
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.